Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berotralstat for HAE Prophylaxis in Children (APeX-P)
NCT05453968Phase 3Active, not recruiting
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Oct 2022
- Primary completion
- Sep 2024
- Countries
- 10
01
Overview
A Phase 3 trial of berotralstat in hereditary angioedema (HAE), sponsored by BioCryst Pharmaceuticals, Inc.. Started Oct 2022; status: active, not recruiting.
02
Drugs
berotralstat
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT05453968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05453968.